Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Inventory (2021 - 2025)

Historic Change in Inventory for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to $3.1 million.

  • Oncology Institute's Change in Inventory rose 35460.53% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 51790.48%. This contributed to the annual value of -$3.6 million for FY2024, which is 18298.75% down from last year.
  • Per Oncology Institute's latest filing, its Change in Inventory stood at $3.1 million for Q3 2025, which was up 35460.53% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Change in Inventory ranged from a high of $3.5 million in Q2 2025 and a low of -$2.1 million during Q1 2024
  • Its 5-year average for Change in Inventory is $692789.5, with a median of $502000.0 in 2021.
  • In the last 5 years, Oncology Institute's Change in Inventory soared by 1342000.0% in 2022 and then plummeted by 2036666.67% in 2024.
  • Oncology Institute's Change in Inventory (Quarter) stood at $502000.0 in 2021, then plummeted by 269.72% to -$852000.0 in 2022, then skyrocketed by 272.77% to $1.5 million in 2023, then crashed by 104.55% to -$67000.0 in 2024, then soared by 4720.9% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $3.5 million for Q2 2025, and $2.3 million during Q1 2025.